Cytel's Series A Round

Cytel raised a round of funding on February 21, 2005. Investors include Merck Capital Ventures.

Cytel is an independent clinical biostatistics research and development organization, helping pharmaceutical, biotech and medical device companies improve clinical success rates via optimal study desi…

Articles about Cytel's Series A Round: